Ortho Clinical Diagnostics Holdings plc
- In Vitro and In Vivo Diagnostic Substances
- Raritan, New Jersey
Compensation history
Top executives at Ortho Clinical Diagnostics Holdings plc received an average of $2M per person in 2021 compensation.
By year
- 2021
CS$6MChristopher SmithChairman and Chief Executive OfficerMI$4MMichael IskraExecutive Vice President, Strategy & Commercial ExcellenceMS$922KMichael A. SchlesingerExecutive Vice President, General Counsel & SecretaryJB$734KJoseph BuskyChief Financial OfficerCP$726KChockalingam PalaniappanChief Innovation Officer
Executives
We found five executives who work or worked at Ortho Clinical Diagnostics Holdings plc.
Christopher Smith
Ortho Clinical Diagnostics Holdings plc
Chief Executive Officer
Joseph Busky
Ortho Clinical Diagnostics Holdings plc
Chief Financial Officer
Michael Iskra
Ortho Clinical Diagnostics Holdings plc
Executive Vice President, Strategy & Commercial Excellence
Chockalingam Palaniappan
Ortho Clinical Diagnostics Holdings plc
Chief Innovation Officer
Michael Schlesinger
Ortho Clinical Diagnostics Holdings plc
General Counsel
News
About Ortho Clinical Diagnostics Holdings plc
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- In Vitro and In Vivo Diagnostic Substances
- 1001 Route 202, Raritan, New Jersey 08869
- (908) 218-8000
- January 2
- Former names
- Ortho-Clinical Diagnostics Bermuda Co. Ltd.